Allergan2525 Dupont Dr Irvine Ca 92612 Pma Numberp050047 Supplement Numbers086 Date Received07 07 2022 Decision Date08 05 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Allergan2525 Dupont Dr Irvine Ca 92612 Pma Numberp050047 Supplement Numbers086 Date Received07 07 2022 Decision Date08 05 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P050047S086 Allergan2525 Dupont Dr.irvine, CA 92612 PMA NumberP050047 Supplement NumberS086 Date Received07/07/2022 Decision Date08/05/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Juvéderm Ultra, Ultra XC, Juvéderm Ultra XC	2022-08-05